Ahmed T. el-Gaili Rejoins as a Partner to Lead the Firm’s Expansion into the Middle East

ABU DHABI, UAE, Sept. 15, 2026 /PRNewswire/ — Sullivan & Cromwell LLP today announced the opening of an office in Abu Dhabi, reinforcing its long-term commitment to the Middle East. Located in ADGM, the international financial center in Abu Dhabi, the capital of the United Arab Emirates, the new office will enhance S&C’s ability to serve clients in the UAE, Saudi Arabia and across the region with its integrated offering, which combines financing, regulatory, and transactional expertise with deep experience working on complex, cross-border, and large-scale mandates.  Ahmed T. el-Gaili will rejoin the firm as a partner to lead the firm’s Middle East practice.

“We are delighted to deepen S&C’s connection to one of the world’s most dynamic financial centers with a new office in Abu Dhabi,” said Robert Giuffra and Scott Miller, Co-Chairs of Sullivan & Cromwell. “Underscoring our long-term commitment to the region, we are pleased to welcome back Ahmed to S&C. He is an outstanding lawyer who is ideally placed to lead our work in the Middle East as we build on the longstanding relationships and track record we have developed advising our clients on their most critical matters across the region.”

Mr. el-Gaili previously practiced at Sullivan & Cromwell for six years in London before relocating to the Middle East. He has nearly two decades of experience in the region advising sovereign wealth funds, state-owned enterprises, governments, leading regional and international corporates, and private equity firms on complex, cross-border transactions and projects. His practice spans M&A, private equity, joint ventures, project finance and development and restructuring, with a particular focus on the energy, infrastructure, life sciences, telecom and technology sectors. He has extensive relationships with leading sovereign wealth funds and state-owned enterprises throughout the Middle East.

“Sovereign capital, private equity and infrastructure investment in the Middle East is fueling some of the most high-profile and complex transactions anywhere in the world, particularly in Saudi Arabia and the UAE,” said Mr. el-Gaili. “S&C’s global platform, integrated offering and depth of expertise make it uniquely positioned to advise the region’s most sophisticated clients on matters where judgment is decisive. I’m delighted to return to S&C and look forward to working with my colleagues across the firm to build our presence in the Middle East at a time of significant activity and growth.”

“We welcome Sullivan & Cromwell to ADGM, the international financial centre of Abu Dhabi, and are pleased to see a leading global law firm establish a presence in our jurisdiction,” said Arvind Ramamurthy, Chief Market Development Officer of ADGM. “Their decision to open an office in ADGM reflects the continued growth of Abu Dhabi as a leading hub for international finance, investment and professional services, and further strengthens the depth of expertise available to regional and global clients operating from ADGM.”

S&C’s expansion into the Middle East will be supported by other firm partners with deep regional experience. Mr. el-Gaili will work closely alongside the wider S&C team, including partner Garth Bray, who brings extensive expertise working on complex cross-border M&A as well as technology and regulatory matters, and Umberto Hassan, whose expertise includes cross-border M&A and complex restructuring, with a focus on clients based in the UAE.

S&C has received full regulatory authorization from ADGM’s Registration Authority.

About Sullivan & Cromwell LLP

Sullivan & Cromwell LLP is a leading global law firm that advises on major domestic and cross-border M&A, significant litigation and corporate investigations, finance and corporate transactions, and complex antitrust, regulatory, tax and estate planning matters. Our Firm’s hallmarks are the highest-quality independent advice and intense dedication to solving client problems. Founded in 1879, S&C has approximately 1,000 lawyers located in offices in New York, Washington, D.C., Los Angeles, Palo Alto, London, Frankfurt, Paris, Brussels, Hong Kong, Beijing, Tokyo, Melbourne, Sydney and Abu Dhabi.

View original content:https://www.prnewswire.com/apac/news-releases/sullivan–cromwell-opens-office-in-adgm-302877921.html

SOURCE ADGM

HANNOVER, Germany, Sept. 15, 2026 /PRNewswire/ — GAC Commercial Vehicle debuted at IAA TRANSPORTATION 2026 under the theme “Delivering the Future Together”, showcasing products, technologies and open-ecosystem achievements across its new-energy heavy and light commercial vehicle businesses.

GAC Commercial Vehicle partners with Pony.ai and Aulton to showcase L4 autonomous driving and efficient battery-swapping solutions based on GAC’s T9 truck. The company’s new light commercial vehicle brand MONTX made its overseas debut with its P10 and V10 concept vehicles, All-Domain Adaptive Architecture (ADAA) and MONTX Makers, its global user product co-creation initiative. The production SMILODON Pro pickup was also displayed.

“Our debut at IAA TRANSPORTATION, one of the world’s most important stages for the commercial vehicle industry, is a key milestone in GAC Commercial Vehicle’s globalization journey. Taking products global is only the starting point; taking our ecosystem global represents a new stage of value co-creation. Leveraging GAC Group’s global resources and working with partners worldwide, we will bring both our vehicle technologies and collaborative ecosystem to global markets, jointly advancing the new-energy commercial vehicle industry toward a more efficient, intelligent and sustainable future,” said Jimmy Du, COO of GAC Commercial Vehicle.

Building on Strength to Accelerate Global Expansion

Building on the mature systems developed through the long-standing GAC Hino joint venture, GAC Commercial Vehicle has nearly two decades of commercial vehicle expertise in R&D, manufacturing and quality management and benefits from the Group’s supply chain and global resources.

GAC Commercial Vehicle’s sales soared 205% year-on-year in the first half of 2026. It is accelerating its global expansion by taking both its products and ecosystem global, building on its domestic new-energy business and leveraging the GAC Group’s sales and service network across 110 countries and regions.

Advancing Through Intelligence to Create Operational Value

GAC’s heavy commercial vehicle business focuses on new-energy heavy-duty trucks. The T9 Robotruck combines Pony.ai’s 4th Generation Autonomous Driving Technology with GAC’s fully redundant drive-by-wire chassis. Its automotive-grade suite includes nine LiDARs, three radars and 13 cameras. Compared with the previous generation, hardware costs are 70% lower and autonomous-driving transportation cost per ton-kilometer is approximately 30% lower, improving efficiency in long-haul, dedicated-route and port transportation.

The T9 Battery Swap EV Tractor combines an electric drive axle with a 603 kWh lithium iron phosphate battery, delivering up to 475 km of range with combined energy consumption as low as 1.2 kWh/km. Aulton’s system enables a full-vehicle battery swap in approximately three to five minutes, reducing downtime and improving vehicle utilization. Charging and battery swapping are complementary solutions for different scenarios, with swapping particularly valuable for fixed-route, high-frequency operations.

Together, GAC Commercial Vehicle, Pony.ai and Aulton have integrated vehicle + autonomous driving + energy capabilities to shorten technology deployment cycles and accelerate scaled application in real-world operations.

MONTX Opens New Growth Opportunities in Light Commercial Vehicles

MONTX expands GAC Commercial Vehicle into new light commercial vehicle categories, exploring new scenarios and user needs for global users. Its P10 and V10 concept vehicles embody All-Domain Aesthetics, All-Domain Adaptability and All-Domain Intelligence.

The MONTX P10 is positioned as the All-Domain Integrated Mobility Platform. It targets explorers and outdoor professionals and is tailor-made for extreme environments. Four distributed drive motors, AI Camp Mode and Intelligent Trailering Assist enhance adaptability across complex terrain for remote exploration, field research and off-road expeditions.

The MONTX V10, positioned as The All-Domain Mobile Station, addresses the needs of digital nomads, creators and travelers. Its modular interior, Dual-Drive Smart Cabin and off-grid self-sustaining capabilities enable seamless transitions between work, rest, socializing and exploration, extending the vehicle into a platform for mobile work and living.

MONTX also unveiled its All-Domain Adaptive Architecture (ADAA). Built with a Multi-Energy by Design, Body-on-Frame by Design and Adaptive Intelligence by Design philosophy, ADAA enables one architecture to accommodate multiple energy types, vehicle forms and applications, improving development efficiency and adaptability across diverse global markets.

MONTX also launched MONTX Makers, its global user co-creation initiative, under “Ideas In. Drive Out.” The program lets users help define future products by incorporating their needs early on in its product design and development process. MONTX Makers may receive MONTX Pioneer Co-Creator recognition, opportunities to attend global brand events and exclusive owner benefits.

The SMILODON Pro production model complements the MONTX concept cars, offering cargo capacity, ride comfort and multi-scenario adaptability for business and everyday life. Already available in Central and South America and the Middle East, it is planned to be available in around 30 countries by the end of 2026.

Delivering the Future Together

GAC Commercial Vehicle will continue strengthening its products through vehicle R&D and manufacturing while connecting global users and partners through its open ecosystem to create greater value and advance its international growth.

Official Website: https://www.gaccv.com/ 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/gac-commercial-vehicle-accelerates-global-expansion-with-iaa-transportation-2026-debut-302877907.html

SOURCE GAC Commercial Vehicle

BEIJING, Sept. 15, 2026 /PRNewswire/ — On September 14, IAA TRANSPORTATION 2026 opened in Hannover. BAIC FOTON presented complete vehicles and self-developed components, with several overseas debuts. It shared its European strategy, global milestones and new flagship products, moving from traditional exports to a full-value-chain international model.

13 Million Vehicles Delivered, Marking a New Milestone in FOTON’s Global Development

BAIC FOTON delivered its 13 millionth vehicle worldwide—the GALAXUS 9, tested in Spain—marking progress in Europe’s premium long-haul market. FOTON operates in over 140 countries. Its 2030 targets: new energy 50% of sales and international sales 40%. Europe is a key hub. Under “In Europe, For Europe,” FOTON focuses on localized products, ecosystem capabilities and partnerships. It offers battery electric, hybrid and hydrogen fuel-cell vehicles—heavy trucks, buses, light commercial vehicles and pickups. It plans a localized new-energy ecosystem, sales in nearly 20 European markets, 300+ service outlets, a German parts center and local assembly by 2028. Its BROCK subsidiary supports connected services.

CAVAN BEACON Makes Its Global Debut, Setting A New Benchmark For Zero-Carbon Intelligent Heavy-Duty Trunk Transport

CAVAN BEACON, a zero-carbon intelligent long-haul heavy truck, debuted globally. Its platform supports 15 variants across battery electric, battery swapping, gaseous and liquid hydrogen. Megawatt fast charging reaches 20–80% in 18 minutes; electric range exceeds 600 km; hydrogen range exceeds 1,000 km. It features ICA/HWP driver assistance, 22 functions and readiness for Level 4. Energy consumption drops 15%; the 6×4 electric uses 115 kWh/100 km. The cab adds comfort, AI voice assistant, dual screens and a 1,000 mm sleeper berth.

A Full Product Lineup On Display, Showcasing FOTON’s Technological Capabilities From Multiple Perspectives

FOTON displayed seven vehicles—GALAXUS R9 PHEV, CAVAN BEACON, eGALAXUS D3, DAYSTAR, CAVAN C1, TUNLAND V9 PHEV, eAURORA—and six key components, including batteries, e-controls, e-axles and megawatt charging. The lineup covers multiple powertrains and global scenarios.

As the industry transforms, BAIC FOTON advances internationalization, new energy and intelligent development, aiming to become a world-class commercial vehicle company.

SOURCE FOTON MOTOR

HANOVER, Germany, Sept. 14, 2026 /PRNewswire/ — Contemporary Amperex Technology Co., Limited (CATL) today unveiled TECTRANS II, its next-generation commercial vehicle battery solution, at IAA Transportation 2026 in Hanover.

“Commercial vehicle electrification is emerging as the third wave of the global energy transition,” said Akin Li, Executive President of CATL Overseas Business. “Across products, energy, services and ecosystem, CATL is poised to work with partners around the world to catch this third wave.”

TECTRANS II: A Modular Platform Built for Commercial Vehicle Electrification

Scenario Adaptability: Designed for diverse commercial vehicle applications and operating requirements.

• One platform for multiple scenarios: By configuring different numbers of standardized battery packs, TECTRANS II can meet different energy capacity and payload requirements and support a maximum driving range of up to 1,000 kilometers.
• Flexible technology routes: The platform is compatible with both e-axle and central-drive architectures and supports flexible switching between charging and battery swapping.
• One Configuration, Lifetime Compatibility: The platform standardizes external dimensions, electrical interfaces and communication protocols while allowing battery technologies and pack designs to evolve. This enables both new and existing vehicle models to benefit from future upgrades without major changes to the vehicle platform.
• The modular design helps OEMs shorten vehicle development cycles by 50% and reduce R&D costs by 60% to 70%, supporting faster model launches and lower adaptation costs.

Lifecycle Economics: Designed to deliver stronger economics across the entire vehicle lifecycle.

• Faster payback: The modular platform eliminates the need to develop dedicated battery systems for each vehicle model, helping OEMs reduce development costs, shorten launch timelines and lower early-stage investment risk.
• Higher operating returns: TECTRANS II improves fleet economics in three ways.
  • Higher energy density: Boasting a gravimetric energy density of 170 Wh/kg, around 13% above the industry average, the battery enables vehicles to carry approximately 0.6 tonnes of additional payload at the same battery capacity.
  • Longer Range, Faster Charging: Its maximum configuration offers up to 1,000 km of range and 80% charging in 25 minutes with megawatt-level fast charging, minimizing downtime on long-haul routes.
  • Higher energy efficiency: The world’s first full-tab low-impedance design enables 96% system round-trip efficiency (RTE), reducing charging losses and delivering more usable energy for daily operations.
• Stronger residual value: The TECTRANS II battery for heavy-duty trucks is engineered for a 12-year, 1.5-million-kilometer service life with 70% capacity retention, helping support stronger residual value for fleet assets.

Safety and Reliability: Built to withstand real-world commercial operations.

• Robust physical protection:

• • Hot-formed steel upper cover: Withstands repeated stepping by an 180-kilogram adult 10,000 times without deformation.
  • Ultra-strong bottom plate: Delivers 1,000 J impact resistance to protect the battery pack from road impacts.
  • High-strength enclosure protection: Uses an extruded-aluminum enclosure with crush-resistant ribs, delivering lateral crush strength up to 250 kN.
  • 15-year corrosion resistance: Supports long-term operation in coastal environments and cold regions.
  • Maintenance-friendly design: Maintains IPXXB protection with the main connectors connected or disconnected, enhancing high-voltage safety during maintenance.

• System redundancy:

• • Architecture redundancy: Multi-branch independent BMS control enables the system to isolate a failed branch while the remaining branches continue to supply power.
  • Precise fault diagnosis: Proprietary insulation fault-location technology can distinguish whether an insulation issue comes from the battery or other vehicle components, enabling faster troubleshooting.
  • Cybersecurity protection: Multi-layer protection from chip hardware and software programs to the vehicle system, following international information security standards throughout development.

TECTRANS II reflects CATL’s long-term commitment to continuous innovation and consistent product quality. In addition, backed by real-world operating experience and rigorous validation, including full-vehicle torsion and external fire testing, the platform is designed for safety, reliability and long service life in demanding commercial vehicle operations.

Partnering to Build Green Freight Corridors Across Europe

At the show, CATL also signed an MoU with DHL Group. Building on the pair’s September 2024 agreement, the MoU will see the two companies develop Green Freight Corridors across Europe. The partners will leverage DHL’s logistics network, operational expertise and real-world transport requirements alongside CATL’s battery technology and electrification ecosystem. They will also work with OEMs and other partners to co-develop purpose-built electric vehicles and launch pilot deployments.

“Commercial vehicle electrification will unfold over more than a decade,” said Zhu Lingbo, CTO of CATL Global Business Unit. “With our deep technological expertise and long-term commitment, CATL is ready to be the most reliable partner for customers worldwide and for the global electrification of freight transport.”

SOURCE Contemporary Amperex Technology Co., Limited (CATL)

TAIPEI, Sept. 14, 2026 /PRNewswire/ — When people hear the name Kao Min-Min, many immediately think of the celebrity nutritionist and health expert who has built a strong professional presence across social media and digital content, reaching an audience of more than one million followers. (Article source from: LIFE NEWS)

Her husband, entrepreneur Liao Po-Yu, has taken a different path, focusing on brand development, integrated marketing, corporate investment, and diversified business ventures.

One stands in front of the camera communicating professional knowledge to the public, while the other works behind the scenes building businesses and developing new markets.

Although the couple has pursued distinct professional paths, their respective ventures have expanded across health, biotechnology, medical aesthetics, animal healthcare, the pet industry, SPA and wellness services, fitness, and international markets. Their complementary careers have earned them growing attention as one of Taiwan’s emerging “Biotech Power Couples.”

Liao’s business interests span a wide range of industries, including medical aesthetics, professional skincare, veterinary healthcare, pet lifestyle services, talent and healthcare professional management, SPA and wellness, and fitness.

His related ventures and brands include Bella Plastic Surgery Clinic, Mabu Animal Hospital, Lucky Paws Pet Grooming & Hotel, LoveIsPet, LOVEISDERMA, NutriMin, and White Coat Alliance, along with businesses in the SPA, wellness, and fitness sectors.

Together, these ventures reflect an increasingly diversified business portfolio spanning multiple areas of health and lifestyle services.

Kao, meanwhile, continues to leverage her professional expertise as a nutritionist and her influence as a health communicator. Her work spans nutrition education, health communication, publishing, social media content, and brand development.

She has also extended her nutrition expertise into the pet nutrition sector through ventures including NutriMin, bringing the concept of nutrition beyond human health and into the growing field of pet wellness.

Importantly, not every business associated with Kao and Liao is jointly operated by the couple. Each has developed businesses independently according to their respective areas of expertise.

For example, professional skincare brand LOVEISDERMA is part of Liao’s business portfolio, while Kao is not involved in the management or operation of the brand.

Starting His Entrepreneurial Journey at 19: Liao Po-Yu Expands from Branding and Marketing into Multiple Industries

While Kao has spent years building a highly visible presence across media and social platforms, Liao has largely focused on the business operations taking place behind the scenes.

Liao began his entrepreneurial journey at the age of 19, gradually building experience across digital marketing, brand strategy, talent management, distribution, and corporate integration.

Over the years, he has also been involved in Taiwan-related business activities for major digital platforms including Kuaishou App and Moko, while participating in and facilitating several major brand merger and acquisition projects.

His career has evolved alongside changes in the digital economy.

Beginning with internet platforms, digital marketing, and brand strategy, Liao later expanded into biotechnology and healthcare, medical aesthetics, professional skincare, veterinary healthcare, and the pet industry.

In recent years, he has further extended his business interests into SPA and wellness services, fitness, and international markets, continuing to broaden the scope of his entrepreneurial portfolio.

One in Front of the Camera, One Behind the Business: A Partnership Built on Complementary Strengths

Kao has long been at the forefront of health communication, using her professional expertise as a nutritionist to translate complex information about nutrition and wellness into practical, accessible content that people can apply in everyday life.

Liao, meanwhile, has focused extensively on corporate management, brand strategy, integrated marketing, distribution networks, investment integration, and cross-border business development.

Their career paths are different, and they do not jointly participate in every business or brand. Instead, their different strengths have shaped a distinctive approach to entrepreneurship and partnership.

“We don’t necessarily have to work on everything together,” Kao said. “We each focus on what we do best and continue moving forward in our own areas. We both have our own stage, but whenever one of us needs support, the other will always be there.”

Rather than following the conventional model in which a married couple jointly operates every business, Kao and Liao have developed their careers independently while supporting each other with resources, experience, and expertise when needed.

From Medical Aesthetics to Pet Healthcare: Liao Po-Yu Builds a Cross-Industry Business Portfolio

In the health and beauty sector, Liao has continued to expand his business interests into medical aesthetics and professional skincare.

His related ventures include Bella Plastic Surgery Clinic and professional skincare brand LOVEISDERMA, extending his business portfolio from brand development into the medical aesthetics and professional skincare markets.

The rapidly growing pet economy has also become an important part of his broader business strategy.

From Mabu Animal Hospital and Lucky Paws Pet Grooming & Hotel to LoveIsPet and NutriMin, the portfolio covers multiple areas of the pet industry, including veterinary healthcare, pet grooming and accommodation, lifestyle products, and nutrition.

Combined with White Coat Alliance, SPA and wellness businesses, and fitness-related ventures, Liao’s portfolio has gradually evolved beyond individual brand management into a diversified business network spanning healthcare, biotechnology, medical services, beauty, pet care, and lifestyle services.

From Taiwan to International Markets: Shanghai and Vietnam Become the Next Stage of Expansion

Their respective ambitions are no longer limited to Taiwan.

As their businesses and related ventures continue to mature, their commercial footprint has gradually expanded into overseas markets, including Shanghai and Vietnam.

From brand development and distribution channels to cross-border partnerships, the couple continues to explore new opportunities across the broader Asian market.

Although Kao and Liao have followed different career paths—as a nutritionist and content creator on one side, and an entrepreneur and business strategist on the other—their work intersects around a shared focus on the health and lifestyle industries.

Kao has built her personal brand through professional nutrition expertise and strong content influence, while Liao has continued to expand his business portfolio through brand strategy, corporate management, investment, and industry integration.

One specializes in turning professional knowledge into messages that resonate with the market; the other specializes in transforming market opportunities into sustainable businesses.

That may be what makes this Taiwanese “Biotech Power Couple” particularly distinctive: they do not have to build every business together. Instead, each shines on their own stage while remaining one another’s strongest source of support when it matters most.

Original source from: https://lifenews.com.tw/579467

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/taiwans-biotech-power-couple-kao-min-min-and-liao-po-yu-reveal-their-expanding-business-portfolio-across-health-and-lifestyle-industries-302877605.html

SOURCE LIFE NEWS

• Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
• Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
• Integrated autoloader and BD FACSChorus™ Software speeds time to insight for new and experienced users.

MILFORD, Mass., Sept. 14, 2026 /PRNewswire/ — Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with industry-leading standardization and ease-of-use features, making the power of advanced flow cytometry more accessible to researchers in academia and pharmaceutical settings, as well as in contract research organization (CRO) labs.

The new cell analyzer expands Waters’ category-defining FACSDiscover platform of flow cytometers, incorporating the same cutting-edge BD SpectralFX Technology present in the flagship BD FACSDiscover A8 Cell Analyzer, which supports up to five lasers and 78 fluorescence detectors to maximize the palette of colors. This technology enables scientists to analyze more than 50 characteristics of a single cell with consistent, high-quality data.

Together with FACSTruQ Technology, a notable product innovation that delivers next-generation instrument calibration with automated setup and quality control, the cell analyzer provides data consistency across instruments, users, and sites, achieving highly reproducible results with a less than 10% coefficient of variation across a palette of more than 50 dyes.¹ Paired with the BD FACSChorus Software’s guided workflows and the integrated autoloader, the FACSDiscover A7 Cell Analyzer sets a new standard for experimental standardization in flow cytometry.

“The FACSDiscover A7 Cell Analyzer lowers the barrier to advanced spectral flow cytometry and will open up new possibilities for immunology research, enabling our core facility to help scientists uncover deeper biological insights with greater standardization and confidence,” said Cheryl Kim, Senior Director, Flow Cytometry Core, La Jolla Institute for Immunology. “We look forward to the FACSDiscover A7 Cell Analyzer being an integral instrument for our core, allowing our researchers to get the most out of spectral data to advance our important work of improving human health through the development of treatments and cures for immune system disorders.”

Steve Conly, Senior Vice President, Waters Biosciences, Waters Corporation, added, “The FACSDiscover A7 Cell Analyzer couples advanced spectral performance and leading standardization with a compelling price-to-performance balance, bringing spectral flow cytometry within reach of more researchers than ever before, for applications from biomarker discovery to drug development. Just two years after the world’s very first 50-color flow cytometry panel was developed on the BD FACSDiscover™ S8 Cell Sorter,² the FACSDiscover A7 Cell Analyzer extends these transformative capabilities, helping labs meet their increasingly critical needs for reproducibility within our connected ecosystem of instruments, reagents, and informatics.”

The FACSDiscover A7 Cell Analyzer is now commercially available globally and available to order through local representatives. For more information, please visit waters.com and bdbiosciences.com/A7.

BD is a trademark of Becton, Dickinson and Company. Waters is a trademark of Waters Corporation or its affiliates.  All other marks are the property of their respective owners.

About Waters Corporation:

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~15,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.

Disclaimer:

The BD Biosciences and BD Diagnostic Solutions businesses have been acquired by Waters Corporation (“Waters”). Becton, Dickinson and Company or one of its affiliates or subsidiaries (“BD”) remains the legal manufacturer of Biosciences and Diagnostic Solutions products until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under BD’s regulatory authority. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary: www.waters.com/bdtransaction.

References:

1) Internal Waters data comparing the BD FACSDiscover™ A7 Cell Analyzer with the BD FACSLyric™ Flow Cytometry System and publicly available data for comparable instruments.

2) Konecny AJ, Mage PL, Tyznik AJ, Prlic M and Mair F. OMIP-102: 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. Cytometry Part A 2024; 105:430-436. DOI: 10.1002/cyto.a.24841 

Contact:

Molly Gluck
Head of External Communications
Waters Corporation
+1.508.498.9732
[email protected]

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/waters-sets-benchmark-for-standardized-spectral-flow-cytometry-with-commercial-launch-of-bd-facsdiscover-a7-cell-analyzer-302877331.html

SOURCE Waters Corporation

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 14, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, announced today that the Company’s Board of Directors has authorized Cellebrite to pursue a corporate reorganization, establishing a new United States corporation as the ultimate parent company, subject to shareholder and regulatory approvals.

Shiv Ramji, Cellebrite’s chief executive officer, said, “Redomiciling is a strategic evolution of our company structure. We believe redomiciling in the U.S. will better position us to drive growth across our key customer segments in our largest geographic market as well as with other large government customers outside of the U.S. Redomiciling will also increase Cellebrite’s appeal across a broader investor pool through inclusion in key indices.”

Cellebrite anticipates that the redomiciling will be completed by the first half of 2027, pending successful shareholder and regulatory approvals. Cellebrite plans to share additional details in the coming months, including those related to a special general meeting of shareholders, through additional filings with the U.S. Securities and Exchange Commission.

Caution Regarding Forward Looking Statements

This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include, but are not limited to, the anticipated timeframe for completing the redomiciling and the anticipated benefits from redomiciling such as it will better position us to drive growth across our key customer segments in our largest geographic market as well as with other large government customers outside of the U.S and that it will increase Cellebrite’s appeal across a broader investor pool through inclusion in key indices. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and challenges and evolving industry standards with respect to software, artificial intelligence, or device access, to adapt to changing market potential within our markets and to successfully launch new solutions and add-ons that meet or exceed customer needs; our material dependence on the acceptance of our solutions by domestic and international law enforcement, public safety, defense and intelligence agencies; real or perceived errors, failures, defects or bugs in our solutions; licensing of technology from third parties, including our dependence on maintaining those licenses or seeking alternative solutions; failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of our markets, including risks associated with pricing pressures from and loss of market share to competitors with greater resources than we have and increasing competition as a result of consolidation in the industry; the misuse of our solutions by our customers which may achieve suboptimal results or be perceived as incompatible with human rights; our ability to properly manage our growth as a business, and execute new offerings, developments and strategic opportunities, including joint ventures, partnerships and acquisitions; our dependence on our customers to renew their subscriptions and purchase additional subscriptions or services from us; conducting a low volume of our business via e-commerce; the use of artificial intelligence in our digital investigation platform; the availability of financing sources on reasonable terms or at all; our reliance on third-party suppliers for certain components, products or services, including risks relating to the availability of raw materials or components; challenges associated with large transactions, including with respect to longer sales cycles, as well as with developing, offering, implementing, and maintaining new solutions; risk of security vulnerabilities or defects, including cyber-attacks, information technology system breaches, failures or disruptions which are critical to our operations and maintaining the trust and confidence of our customers; risks associated with political, geo-political and reputational factors related to our business or operations, including Cellebrite operations in Israel and/or negative publicity, including with respect to the nature of our solutions; risks associated with our ability to obtain CFIUS approval for the acquisition of Corellium and with our ongoing compliance with national security agreements entered into with the U.S. government; risks that our intellectual property rights may not be adequate to protect our business or assets or that others may make claims on our intellectual property, claim infringement on their intellectual property rights, or claim a violation of their license rights, including relative to free or open-source-software components we may use risks relating to the regulatory constraints to which we are subject, including Israeli export laws, our compliance with such laws and related export licenses issued from the government of Israel; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer; risks associated with our significant international operations, including due to our Israeli operations, fluctuations in foreign exchange rates, rising global inflation, and exposure to regions subject to political or economic instability, including the State of Israel; uncertainties regarding the impact of changes in macroeconomic and/or global conditions, including as a result of slowdowns, recessions, economic instability, political unrest, or outbreaks of disease, as well as the resulting impact on information technology spending and government budgets, on our business and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20-F filed with the U.S. Securities and Exchange Commission (“SEC”) on March 3, 2026, and in other documents filed by Cellebrite with the SEC, which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

About Cellebrite

Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

Contacts:

Investors Relations
Andrew Kramer
Vice President, Investor Relations & Treasury
[email protected]
+1 973.206.7760

Media
Jackie Labrecque
Director, PR and Executive Communications
[email protected]  
+1 771.241.7010

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cellebrite-initiates-plans-to-redomicile-in-the-united-states-302877362.html

SOURCE Cellebrite

A robust five-year pipeline of new developments and enhancements will expand world-class attractions, grow hotel capacity, and further strengthen Yas Island’s global appeal

ABU DHABI, UAE, Sept. 14, 2026 /PRNewswire/ — Miral, Abu Dhabi’s leading creator of immersive destinations and experiences, will be investing more than AED 12 billion across Yas Island over the next five years. The substantial investment will support a pipeline of new developments alongside expansions and enhancements to existing attractions, reinforcing Miral’s commitment to Abu Dhabi’s Tourism Strategy 2030 and further strengthening Yas Island’s position as a leading global destination for leisure and entertainment.

To view the Multimedia News Release, please click:  
https://www.multivu.com/miral/9421351-en-miral-invests-aed-12-billion-next-phase-yas-islands-growth

This next phase of development reflects a clear focus on expanding Yas Island’s existing world-class theme parks and attractions, as well as introducing new immersive rides and experiences, that respond to evolving visitor expectations. The investment will also grow the island’s hospitality offering, adding new hotel rooms and elevating its accommodation portfolio.

H.E. Mohamed Khalifa Al Mubarak, Chairman of Miral, said, “This investment reflects our commitment to Abu Dhabi’s long-term vision and our ambition to continue shaping one of the world’s most dynamic tourism destinations. Yas Island has become a global success story, demonstrating how world class experiences contribute to economic growth, enhance quality of life, and strengthen Abu Dhabi’s appeal to audiences from around the world.

Over the next five years, this investment will build on that momentum, introducing new experiences and expanding our hospitality and leisure offering to meet our evolving visitor expectations. As Abu Dhabi continues to strengthen its position as a global center for tourism and entertainment, we remain focused on creating lasting value for residents, visitors and future generations, while contributing to the emirate’s sustainable growth and diversification ambitions.”

The AED 12 billion investment, separate from the previously announced Disney project, marks an important step in shaping the long-term growth of Yas Island, building on its established appeal and continuing to enhance its diversity of experiences.

These projects are designed to further enrich the visitor experience, while also supporting job creation and skills development within the tourism sector, thereby fostering a vibrant and future-ready economy for the emirate.

This investment demonstrates Miral’s continued ambition to shape the future of leisure and entertainment in Abu Dhabi and the region, signaling the evolution of Yas Island’s world-class attractions and experiences that will captivate and delight visitors from around the globe for generations to come.

For more information, visit www.miral.ae      

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/miral-invests-aed-12-billion-to-shape-the-next-phase-of-yas-islands-growth-302877729.html

SOURCE Miral

AI-accelerated vulnerability discovery is increasing application updates and shortening remediation deadlines. Devicie’s AI-assisted automation handles the operational work required to keep Windows and macOS applications current within Microsoft Intune.

SYDNEY and TAMPA BAY, Fla., Sept. 14, 2026 /PRNewswire/ — Microsoft Intune gives organizations comprehensive control over their end-user computing environment, but realizing its full value requires teams to continuously operate and maintain it. As AI accelerates vulnerability discovery and increases the volume and urgency of application updates, that operational burden is growing.

Devicie today announced a major expansion of the application management capabilities within its Intune management and automation platform, designed to automate that work rather than add more work for IT teams to manage.

Devicie now automatically manages more than 1,500 Windows and macOS applications, alongside an organization’s own line-of-business software at no additional charge. Devicie’s investment in AI-assisted testing and validation enables new application versions to be made ready within Microsoft Intune, typically within hours of publisher release.

The expansion is part of Devicie’s broader approach to Microsoft Intune: automate the ongoing endpoint operations required to keep environments current, secure and aligned to policy, while organizations retain Microsoft Intune as their management platform.

Application updates are accelerating
The volume and frequency of application security updates are increasing sharply. On 8 September 2026 Microsoft’s monthly security update addressed more than 950 vulnerabilities in a single release — Jerry Gamblin’s analysis of the CVE List records 1,255 Microsoft CVEs across the whole of 2025. In July 2026 Adobe moved from monthly to twice-monthly security bulletins, giving the reason plainly: “the window between public vulnerability disclosure and active exploitation is compressing from days to hours.”

Software publishers attribute the shift in part to AI-assisted vulnerability discovery. Microsoft’s Pavan Davuluri said, “The pace of vulnerability discovery is changing with advances in AI making it possible to find more issues, faster, across more code,” with customers seeing “a higher volume of security updates included in each security release.”

Remediation deadlines have moved with it. In June 2026 the U.S. Cybersecurity and Infrastructure Security Agency replaced its earlier fourteen-day deadline for known exploited vulnerabilities with a tiered directive whose fastest tier is three days and stated that threat actors’ “use of AI may further narrow the time defenders have to react between patch release and possible exploitation.”

Matching the increasing speed
Detection has accelerated. The work required to make updates ready for deployment has to accelerate with it, and at the volume publishers are now shipping, that is not a staffing problem an organization can hire its way out of.

Devicie’s investment in AI-assisted testing and hardening allows its application catalog to be kept current at this pace. Applications are monitored against publisher release sources, then packaged, tested and made ready for assignment, typically within hours of release.

“The U.S. government just cut its remediation deadline for known exploited vulnerabilities from fourteen days to three. Enterprise remediation SLAs written for a slower world are heading in the same direction. You cannot meet that pace by adding more manual work. It requires automation, and automation at this speed requires trust.

That matters beyond application updates. Intune can do far more than most organizations have had the time to switch on. The teams we work with aren’t short of capability; they’re short of hours. Our investment in AI is about building trusted automation that gives teams that capacity back — so they can do more with Intune as endpoint operations become faster and more demanding,” said Alex Hesterberg, Chief Executive Officer at Devicie.

Endpoint operations are becoming critical
Microsoft Intune is among the most capable device management platforms available. The challenge is not what Intune can do; it is the capacity required to operate it continuously and take advantage of its full capabilities.

Application management is among the most time-consuming of those recurring operations. Every new version means finding the installer, determining the correct installation parameters, testing it, packaging it and assigning it; then doing it again when the next version ships.

Devicie automates that function inside the organization’s existing Intune tenant, without requiring an IT team to raise a request. And where a commercial application catalog stops, Devicie continues: an organization’s own line-of-business and in-house software is automated through the same process.

The catalog spans widely used software including Microsoft 365 Apps, Microsoft Visual Studio Code, Microsoft OneDrive, Google Chrome, Adobe Acrobat, Slack, Zoom Workplace and Mozilla Firefox. Coverage is prioritized based on what Devicie detects across its customer base and market monitoring, with new applications added continuously.

Do more with Microsoft Intune

Capacity, back where it is worth more. Application updating stops competing for IT attention, giving teams more capacity for the parts of Intune they have not had time to turn on.

One answer when someone asks. Application currency is reported per device from the same system that reports CIS and ACSC Essential Eight baseline compliance for Windows and macOS end-user devices.

The software the business actually runs is included at no additional charge. Line-of-business systems, in-house tools and vendor applications with complex installers can be managed alongside Devicie’s application catalog.

A version that causes a problem can be rolled back. Devicie keeps the current version and the two versions before it in the tenant, preserving the ability to step back from an update.

macOS managed to the same standard, in the same place. Administrators browse, configure and deploy macOS applications from the same portal, with the same controls, natively through Intune, avoiding the need for a second application management vendor for mixed fleets.

In production today
John Holland Group runs cloud-native device management across more than 60 worksites with Devicie’s enhanced application management in production and full ACSC Essential Eight maturity level one compliance, and reports $1.2 million in annual return.

Toyota Financial Services retired Microsoft Configuration Manager and moved a 1,300-device fleet to modern management on Intune with Devicie, reducing device builds to 20 minutes.

Microsoft Intune remains the control plane
Devicie runs inside the customer’s existing Microsoft stack and change process. There is no second console, no separate source of truth and no migration.

Microsoft controls how often a device checks in, while the organization’s own update rings control how fast a version reaches production. Devicie shortens the time it takes for an application to become ready for deployment while leaving device check-in and production rollout to Microsoft Intune and the customer’s own policies.

Automation at speed requires trust
Every installer must arrive over HTTPS from a domain belonging to the publisher; mirrors, third parties and shortened links are rejected. The file’s cryptographic hash is calculated from the installer itself and compared again at each stage.

Every package is scanned for malware, then installed, detected and removed on a clean machine across every architecture and installation scope it supports. AI accelerates Devicie’s ability to monitor, package and test applications, but it does not replace these deterministic controls. If validation fails, the process stops before the package reaches the customer tenant.

How many of your applications are covered?
Devicie has published a free calculator that allows organizations to compare their Intune application estate against Devicie’s managed coverage and estimate the operational time currently spent managing applications.

Exporting an application list from Intune shows how much of the estate Devicie already covers, which applications have no catalog match and an estimate of the hours per year that work is consuming. Matching runs in the browser; no account or email address is required, and nothing is uploaded.

[Check your application coverage → Intune ROI Calculator: count the hours automation gives back | Devicie]

Devicie manages Windows and macOS end-user devices; servers are out of scope.

About Devicie
Devicie is an Intune management and automation platform that automates the ongoing endpoint operations required to configure, secure and maintain Windows and macOS environments in Microsoft Intune. It connects to an organization’s Microsoft Intune tenant through a secure Microsoft Entra enterprise application and deploys tested security baselines, including CIS benchmarks and ACSC Essential Eight, alongside automated application management and structured update rings. Every managed policy is checked hourly and returned to its intended state if it drifts.

Devicie is a member of the Microsoft Intelligent Security Association, holds SOC 2 Type II and SOC 3 certifications, and is GDPR compliant. Infrastructure runs on Microsoft Azure. Compliance documentation is available through the Devicie Trust Center.

For more information, press only:
Miluse Najmr, Head of Global Marketing
+1 (617) 640-3802
[email protected]

View original content:https://www.prnewswire.com/apac/news-releases/devicie-makes-application-management-automatic-within-microsoft-intune-matching-the-speed-of-ai-302876877.html

SOURCE Devicie

Advancing patient-centric innovation and next-generation therapy delivery in positive airway pressure devices through clinically validated multi-mode technology and enhanced comfort performance

SAN ANTONIO, Sept. 14, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that SleepRes has been recognized with the 2026 North America New Product Innovation Recognition in the Positive Airway Pressure Devices industry for its outstanding achievements in product innovation, clinical differentiation, and patient-centric therapy design. This recognition highlights SleepRes’ leadership in advancing measurable clinical outcomes, and redefining comfort-driven innovation within an evolving sleep therapy landscape.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. SleepRes excelled in both, demonstrating its ability to align innovation with evolving clinical and market requirements while executing with precision, scalability, and regulatory alignment. “The Kricket PAP device supports KPAP, traditional CPAP, and APAP modes within a single platform. This multi-mode architecture enables seamless clinician adoption without forcing protocol changes and aligns with existing reimbursement and prescribing frameworks,” said Utkarsha Soundankar, Industry Analyst, Frost & Sullivan.

Guided by a long-term innovation strategy centered on clinical validation, physician-led design, and platform flexibility, SleepRes has demonstrated strong adaptability in a rapidly evolving Positive Airway Pressure (PAP) market. The company’s strategic focus on integrating algorithmic intelligence with established clinical workflows has enabled efficient excitement across healthcare settings while supporting continuity of care and reimbursement alignment.

Innovation remains central to SleepRes’ approach. Its flagship Kricket™, powered by KPAP™, introduces a differentiated PAP therapy experience that dynamically adjusts pressure delivery in real time, aligning with patient respiration to improve comfort without compromising therapeutic efficacy. “We’re honored to receive this recognition from Frost & Sullivan. It validates our belief that sleep therapy can be both clinically effective and significantly more comfortable for patients, and we’re proud to bring that vision to market.” – John Lipman, CEO at SleepRes.

Frost & Sullivan commends SleepRes for setting a high standard in product innovation, clinical integration, and patient-centric design within the Positive Airway Pressure Devices industry. The company’s vision, supported by FDA 510(k) clearance and a strong clinical foundation, is shaping the future of sleep therapy by enabling more natural, effective, and scalable treatment experiences.

Each year, Frost & Sullivan presents the New Product Innovation Recognition to a company that demonstrates outstanding development and implementation, resulting in measurable improvements in market impact, product differentiation, and competitive positioning. The recognition honors forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:
Ashley Shreve
E: [email protected] 

About SleepRes, Inc.

SleepRes is a sleep and respiratory health technology company dedicated to transforming the treatment of obstructive sleep apnea through thoughtful design, advanced engineering, and patient-first innovation. Powered by its proprietary KPAP™ technology, Kricket™ is building a new generation of sleep therapy solutions that prioritize comfort, and long-term health outcomes.
For more information, visit www.kricket.com.

SOURCE Frost & Sullivan